FDA-2024-0001-V301

Major variation for application FDA-2024-0001. Major variation: Specification Change for Kcluximab — minor update

Variation Number
FDA-2024-0001-V301
Type
Major
Application
FDA-2024-0001
Change
CHG-2024-0001
Status
Approved
Fee
€15,286
Submitted
2022-11-07
Approved
2024-03-05
Description

Major variation: Specification Change for Kcluximab — minor update